399 related articles for article (PubMed ID: 1735605)
1. Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium.
Chang K; Pastan I; Willingham MC
Int J Cancer; 1992 Feb; 50(3):373-81. PubMed ID: 1735605
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 present on ovarian cancers and normal mesothelium.
Chang K; Pai LH; Batra JK; Pastan I; Willingham MC
Cancer Res; 1992 Jan; 52(1):181-6. PubMed ID: 1727378
[TBL] [Abstract][Full Text] [Related]
3. Frequent expression of the tumor antigen CAK1 in squamous-cell carcinomas.
Chang K; Pastan I; Willingham MC
Int J Cancer; 1992 Jun; 51(4):548-54. PubMed ID: 1351045
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody against human ovarian tumor-associated antigens.
Poels LG; Peters D; van Megen Y; Vooijs GP; Verheyen RN; Willemen A; van Niekerk CC; Jap PH; Mungyer G; Kenemans P
J Natl Cancer Inst; 1986 May; 76(5):781-91. PubMed ID: 3517452
[TBL] [Abstract][Full Text] [Related]
5. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
Friedman EL; Hayes DF; Kufe DW
Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a monoclonal antibody, OVB1, which binds to a unique determinant in human ovarian carcinomas and myeloid cells.
Kurrasch RH; Rutherford AV; Rick ME; Gallo MG; Lovelace ET; Pastan I; Willingham MC
J Histochem Cytochem; 1989 Jan; 37(1):57-67. PubMed ID: 2461982
[TBL] [Abstract][Full Text] [Related]
7. Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies.
Mattes MJ; Cordon-Cardo C; Lewis JL; Old LJ; Lloyd KO
Proc Natl Acad Sci U S A; 1984 Jan; 81(2):568-72. PubMed ID: 6582512
[TBL] [Abstract][Full Text] [Related]
8. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types.
Kabawat SE; Bast RC; Welch WR; Knapp RC; Colvin RB
Am J Clin Pathol; 1983 Jan; 79(1):98-104. PubMed ID: 6336888
[TBL] [Abstract][Full Text] [Related]
9. Development of two new monoclonal antibodies reactive to a surface antigen present on human ovarian epithelial cancer cells.
Xu FJ; Yu YH; Li BY; Moradi M; Elg S; Lane C; Carson L; Ramakrishnan S
Cancer Res; 1991 Aug; 51(15):4012-9. PubMed ID: 1855217
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies against CA125-bearing antigenic molecule fragments; reactivity with mucinous ovarian tumours and lung cancers.
Imai S; Maeda H; Kiyozuka Y; Morimoto J; Haga S; Noda T; Hiroishi S; Hilgers J
Mol Cell Probes; 1991 Feb; 5(1):55-63. PubMed ID: 2017201
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody, Mab 12C3, is a sensitive immunohistochemical marker of early malignant change in epithelial ovarian tumors.
Yamada K; Ohkawa K; Joh K
Am J Clin Pathol; 1995 Mar; 103(3):288-94. PubMed ID: 7872250
[TBL] [Abstract][Full Text] [Related]
12. Characterization and distribution in human tissues of a glycoproteic antigen defined by monoclonal antibody 1BE12 raised against the human breast cancer cell line T47D.
Pancino G; Charpin C; Osinaga E; Betaille B; Le Roy M; Calvo F; Roseto A
Cancer Res; 1990 Nov; 50(22):7333-42. PubMed ID: 2224861
[TBL] [Abstract][Full Text] [Related]
13. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells.
Mattes MJ; Look K; Furukawa K; Pierce VK; Old LJ; Lewis JL; Lloyd KO
Cancer Res; 1987 Dec; 47(24 Pt 1):6741-50. PubMed ID: 3677104
[TBL] [Abstract][Full Text] [Related]
14. Antibody-antigen complex formation following injection of OC125 monoclonal antibody in patients with ovarian cancer.
Haisma HJ; Battaile A; Stradtman EW; Knapp RC; Zurawski VR
Int J Cancer; 1987 Dec; 40(6):758-62. PubMed ID: 3480271
[TBL] [Abstract][Full Text] [Related]
15. Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity.
Miotti S; Canevari S; Ménard S; Mezzanzanica D; Porro G; Pupa SM; Regazzoni M; Tagliabue E; Colnaghi MI
Int J Cancer; 1987 Mar; 39(3):297-303. PubMed ID: 2434438
[TBL] [Abstract][Full Text] [Related]
16. Studies of a tumor-associated antigen, COX-1, recognized by a monoclonal antibody.
Lee CY; Chen KW; Sheu FS; Tsang A; Chao KC; Ng HT
Cancer Immunol Immunother; 1992; 35(1):19-26. PubMed ID: 1611619
[TBL] [Abstract][Full Text] [Related]
17. Normal tissue reactivity of four anti-tumor monoclonal antibodies of clinical interest.
Stein R; Goldenberg DM; Mattes MJ
Int J Cancer; 1991 Jan; 47(2):163-9. PubMed ID: 1988361
[TBL] [Abstract][Full Text] [Related]
18. Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies.
Tsuji Y; Suzuki T; Nishiura H; Takemura T; Isojima S
Cancer Res; 1985 May; 45(5):2358-62. PubMed ID: 2580620
[TBL] [Abstract][Full Text] [Related]
19. Human monoclonal antibody recognizing an antigen associated with ovarian and other adenocarcinomas.
Smith LH; Yin A; Glasky MS; Tyler N; Robles M; Foster CA; Bieber M; Teng NN
Am J Obstet Gynecol; 1992 Feb; 166(2):634-45. PubMed ID: 1371375
[TBL] [Abstract][Full Text] [Related]
20. Immunopathologic analysis of a panel of mouse monoclonal antibodies reacting with human ovarian carcinomas and other human tumors.
Cordon-Cardo C; Mattes MJ; Melamed MR; Lewis JL; Old LJ; Lloyd KO
Int J Gynecol Pathol; 1985; 4(2):121-30. PubMed ID: 3894261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
